The effect of LIGHT in inducing maturation of monocyte-derived dendritic cells from MDS patients

Cancer Immunology, Immunotherapy

Volumn 53, Issue 8, 2004, Pages 681-689

  Zou, Gang Ming ^a,c   Martinson, Jeff ^a   Hu, Wen Yang ^a   Tam, Ying ^b   Klingemann, Hans G ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b Inex Pharmaceuticals   (Canada)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD40L; Dendritic cells; LIGHT; MDS; Monocytes

Indexed keywords

CD40 LIGAND; CYTOKINE; TUMOR NECROSIS FACTOR;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL STIMULATION; DENDRITIC CELL; DRUG EFFECT; HUMAN; IMMUNOREGULATION; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; MIXED LYMPHOCYTE REACTION; MONOCYTE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; T LYMPHOCYTE; UPREGULATION;

EID: 3242735551     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-004-0518-8     Document Type: Article

References (38)

1. Steinman RM (1991) The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271
2. Austyn JM, Steinman RM, Weinstein DE, Granelli-Piperno A, Palladino MA (1983) Dendritic cells initiate a two-stage mechanism for T lymphocyte proliferation. J Exp Med 157:1101
3. Paglia P, Chiodoni C, Rodolfo M, Colombo MP (1996) Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J Exp Med 183:317
4. Porgador A, Snyder D, Gilboa E (1996) Induction of antitumor immunity using bone marrow-generated dendritic cells. J Immunol 156:2918
5. Cella M, Sallusto F, Lanzavecchia A (1997) Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 9:10
6. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J (1992) GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 360:258
7. Young JW, Szabolcs P, Moore MA (1995) Identification of dendritic cell colony-forming units among normal human CD34 + bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha. J Exp Med 182:1111
8. + leukocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4. J Leuk Biol 59:208
9. Steinbach F, Krause B, Blass S, Burmester GR, Hiepe F (1998) Development of accessory phenotype and function during the differentiation of monocyte-derived dendritic cells. Res Immunol 149:627
10. Sallusto F, Lanzavecchia A (1994) Efficient presentation of soluble antigen by cultured dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated y tumor necrosis factor-a. J Exp Med 179:1109
11. + dendritic cells. Proc Natl Acad Sci U S A 93:2588
12. Chapuis F, Rosenzwajg M, Yagello M, Ekman M, Biberfeld P, Gluckman JC (1997) Differentiation of human dendritic cells from monocytes in vitro. Eur J Immunol 27:431
13. Romani N, Reider D, Heuer M, Ebner S, Kampgen E, Eibl B, Niederwieser D, Schuler G (1996) Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods 196:137
14. Liu YJ (2000) Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 106:259
15. Zou GM, Tam YK (2002) Cytokines in the generation and maturation of dendritic cells: recent advances. Eur Cytokines Netw 13:186
16. Mauri DN, Ebner R, Montgomery RI, Kochel KD, Cheung TC, Yu GL, Ruben S, Murphy M, Eisenberg RJ, Cohen GH, Spear PG, Ware CF (1998) LIGHT, a new member of the TNF superfamily and lymphotoxin a are ligands for herpesvirus entry mediator. Immunity 8:21
17. Tamada K, Shimozaki K, Chapoval AI, Zhai Y, Su J, Chen SF, Hsieh SL, Nagata S, Ni J, Chen L (2000) LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J Immunol 164:4105
18. Morel Y, Truneh A, Sweet RW, Olive D, Costello RT (2001) The TNF superfamily members LIGHT and CD154 (CD40 ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activity. J Immunol 167:2479
19. Vicari AP, Caux C, Trinchieri G (2002) Tumour escape from immune surveillance through dendritic cell inactivation. Semin Cancer Biol 12:33
20. Kusmartsev S, Gabrilovich DI (2002) Immature myeloid cells and cancer-associated immune suppression. Cancer Immunol Immunother 51:293
21. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C (1982) Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51:189
22. Raza A, Meyer P, Dutt D, Zorat F, Lisak L, Nascimben F, du Randt M, Kaspar C, Goldberg C, Loew J, Dar S, Gezer S, Venugopal P, Zeldis J (2001) Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromes. Blood 98:958
23. Hamblin TJ Immunological abnormalities in myedodysplastic syndrome (1996) Semin Hematol 33:150
24. Fujii S, Shimizu K, Klimek V, Geller MD, Nimer SD, Dhodapkar MV (2003) Severe and selective deficiency of interferon-gamma-producing invariant natural killer T cells in patients with myelodysplastic syndromes. Br J Haematol 122:617
25. Sepp N, Zwierzina H, Smolle J, Schmalzl F, Fritsch P, Schuler G (1991) Epidermal Langerhans cells in myelodysplastic syndromes are abnormal. J Invest Dermatol 96:932
26. Rigolin GM, Howard J, Buggins A, Sneddon C, Castoldi G, Hirst W Jr, Mufti GJ (1999) Phenotypic and functional characteristics of monocyte-derived dendritic cells from patients with myelodysplastic syndromes. Br J Haematol 107:844
27. Chen B, Shi Y, Smith JD, Choi D, Geiger JD, Mule JJ (1998) The role of tumor necrosis factor alpha in modulating the quantity of peripheral blood-derived, cytokine-driven human dendritic cells and its role in enhancing the quality of dendritic cell function in presenting soluble antigens to CD4+ T cells in vitro. Blood 91:4652
28. Radvanyi LG, Banerjee A, Weir M, Messner H (1999) Low levels of interferon-α induce CD86 (B7.2) expression and accelerates dendritic cell maturation from human peripheral blood mononuclear cells. Scand J Immunol 50:499
29. Hart D (1997) Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 90:3245
30. Steinman RM, Pack M, Inaba K (1997) Dendritic cell development and maturation. Adv Exp Med Biol 417:1
31. Luft T, Pang KC, Thomas E, Hertzog P, Hart DN, Trapani J, Cebon J (1998) Type I IFNs enhance the terminal differentiation of dendritic cells. J Immunol 161:1947
32. Fong L, Brockstedt D, Benike C, Breen JK, Strang G, Ruegg CL, Engleman EG (2001) Dendritic cell-based xenoantigen vaccination for prostate cancer immunotherapy. J Immunol 167:7150
33. Ashley DM, Faiola B, Nair S, Hale LP, Bigner DD, Gilboa E (1997) Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors. J Exp Med 186:1177
34. Takahashi T, Tanaka Y, Nieda M, Azuma T, Chiba S, Juji T, Shibata Y, Hirai H (2003) Dendritic cell vaccination for patients with chronic myelogenous leukemia. Leuk Res 27:795
35. Harrop JA, McDonnell PC, Brigham-Burke M, Lyn SD, Minton J, Tan KB, Dede K, Spampanato J, Silverman C, Hensley P, DiPrinzio R, Emery JG, Deen K, Eichman C, Chabot-Fletcher M, Truneh A, Young PR (1998) Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/ TR2, stimulates proliferation of T cells and inhibits HT29 cell growth. J Biol Chem 273:27548
36. Wang J, Chun T, Lo JC, Wu Q, Wang Y, Foster A, Roca K, Chen M, Tamada K, Chen L, Wang CR, Fu YX (2001) The critical role of LIGHT, a TNF family member, in T cell development. J Immunol 167:5099
37. Vuckovic S, Fearnley DB, Gunningham S, Spearing RL, Patton WN, Hart DN (1999) Dendritic cells in chronic myelomonocytic leukemia. Br J Haematol 105:974
38. Brown RD, Pope B, Murray A, Esdale W, Sze DM, Gibson J, Ho PJ, Hart D. Joshua D (2001) Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-β1 and interleukin-10. Blood 98:2992